Can anyone articulate the value of the value based care in chronic kidney disease in the era of the #4pillars? Trad #VBC was based on the premise that generic angiotensin blockade was sufficient (false) and underutilized (proven to be wrong by the #UPMC trial that demonstrated that the perceived underutilization was just the ceiling of these therapies). Since most #VBC worked with Medicare Part B (which does not cover drugs), they can not even pay for the #4pillars.